secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001493152-25-013415
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs shareholders approve share increase to 1B and equity plans
------------------------------------------------------------------------

- Shareholders approved increase in authorized common shares from 50M to 1B at Sept 9 special meeting.
- Approved amendments to 2022 equity plan and 2025 equity plan, enabling executive participation.
- Warrants to CEO Ted Karkus and an investor for 500k shares each now fully exercisable.
- Company can now reserve 400% of shares for conversion of July 2025 20% OID notes and warrants.
- Bylaw amendment to update principal office address approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315225013415/0001493152-25-013415-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315225013415/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013415

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer